Acción SKVI SKINVISIBLE, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Skinvisible, Inc.

Acciones

SKVI

US8307032032

Mercado cerrado - OTC Markets
Otros sitios de cotización
 21:48:16 07/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,4988 USD +1,80 % Gráfico intradía de Skinvisible, Inc. +137,52 % +495,23 %
15/05 Skinvisible, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
16/04 Skinvisible, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Skinvisible, Inc. announced that it has received $0.035 million in funding
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Skinvisible, Inc. Auditor Raises 'Going Concern' Doubt
SKINVISIBLE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción SKVI
  4. Noticias Skinvisible, Inc.
  5. Otros idiomas